XML 37 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development 19,665 23,269
General and administrative 5,250 7,033
Restructuring charges 1,944  
Total operating expenses 26,859 30,302
Loss from operations (26,859) (30,302)
Other income (expense):    
Interest income 164 508
Other income 1 212
Total other income (expense), net 165 720
Net loss $ (26,694) $ (29,582)
Net loss per share attributable to common stockholders, basic and diluted $ (0.56) $ (0.85)
Weighted average shares of common stock outstanding, basic and diluted 48,059,279 34,776,488